CHRISTINA VASQUEZ: Open Payments
NPI 1649933516 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,519 in 80 payments from 13 companies in 2025. Trend: 2023 $373 · 2024 $1,276 · 2025 $1,519
Food & beverage: $1,506Education: $13
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 15 | $331 |
| Vanda Pharmaceuticals Inc. | 10 | $176 |
| Otsuka America Pharmaceutical, Inc. | 11 | $173 |
| Axsome Therapeutics, Inc. | 9 | $157 |
| Janssen Pharmaceuticals, Inc | 5 | $149 |
| ABBVIE INC. | 9 | $143 |
| Supernus Pharmaceuticals, Inc. | 9 | $128 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $97 |
| Almatica Pharma LLC | 2 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $50 |
Products named: LYBALVI, FANAPT, REXULTI, Auvelity, SPRAVATO, VRAYLAR, Qelbree, ARISTADA.
Industry payments across TX — which companies pay providers there.
